PAPER Krishnamurthy PK, Deng Y, Sigurdsson EM
SEARCH RESULTS
331254 RESULTS
PAPER Koller M
[BPSD: behavioural and psychological symptoms of dementia].
MMW Fortschr Med. 2011 Apr 7;153(14):54-7. PubMed: 21966871PAPER Slemmon JR, Meredith J, Guss V, Andreasson U, Andreasen N, Zetterberg H, Blennow K
Measurement of Aβ1-42 in cerebrospinal fluid is influenced by matrix effects.
J Neurochem. 2012 Jan;120(2):325-33. PubMed: 22023354PAPER Guan X, Tu C, Li M, Hu Z
HSP22 and its Role in Human Neurological Disease.
Curr Neurovasc Res. 2011 Nov 1;8(4):323-33. PubMed: 22023611PAPER Shimamura M, Sato N, Morishita R
Experimental and clinical application of plasmid DNA in the field of central nervous diseases.
Curr Gene Ther. 2011 Dec 1;11(6):491-500. PubMed: 22023479PAPER Gomar JJ, Harvey PD, Bobes-Bascaran MT, Davies P, Goldberg TE
Development and cross-validation of the UPSA short form for the performance-based functional assessment of patients with mild cognitive impairment and Alzheimer disease.
Am J Geriatr Psychiatry. 2011 Nov;19(11):915-22. PubMed: 22024615PAPER Antoniades D, Katopodi T, Pappa S, Lampropoulos A, Konsta V, Frydas E, Mpalogiannis S, Hatzistilianou M
The role of reelin gene polymorphisms in the pathogenesis of Alzheimer's disease in a Greek population.
J Biol Regul Homeost Agents. 2011 Jul-Sep;25(3):351-8. PubMed: 22023759PAPER Lee S, Sato Y, Nixon RA
Primary lysosomal dysfunction causes cargo-specific deficits of axonal transport leading to Alzheimer-like neuritic dystrophy.
Autophagy. 2011 Dec;7(12):1562-3. PubMed: 22024748Reisa Sperling on An Operational Approach to NIA-AA Criteria for Preclinical Alzheimer’s Disease.
COMMENT Overall, I think this is an important step forward in validating the preclinical staging framework in a well-characterized sample drawn from a community-dwelling cohort. The designation of additional categories is useful to provide a classification scheme
PAPER Jack CR, Knopman DS, Weigand SD, Wiste HJ, Vemuri P, Lowe V, Kantarci K, Gunter JL, Senjem ML, Petersen RC
An Operational Approach to NIA-AA Criteria for Preclinical Alzheimer’s Disease.
Ann Neurol. 2011 Oct 1;Allen Frances on Two New Sets of Diagnostic Criteria—Which Is Right for Your Clinic?
COMMENT Guidelines Can Be Bad for Public Health The diagnosis of mild cognitive impairment as a prodrome to Alzheimer's disease (MCI due to AD) will someday be an important milestone in the clinical application of neuroscience. Laboratories around the world
Ilya Bezprozvanny on Single-channel Ca(2+) imaging implicates Aβ1-42 amyloid pores in Alzheimer's disease pathology.
COMMENT This is an elegant paper that uses the “optical patch clamp” method to resolve individual calcium transients resulting from incorporation of Aβ42 oligomers into the membrane. Previous electrophysiological recordings of Aβ42-induced channels in lipid bilay
PAPER Demuro A, Smith M, Parker I
Single-channel Ca(2+) imaging implicates Aβ1-42 amyloid pores in Alzheimer's disease pathology.
J Cell Biol. 2011 Oct 31;195(3):515-24. PubMed: 22024165PAPER Mott RT, Ait-Ghezala G, Town T, Mori T, Vendrame M, Zeng J, Ehrhart J, Mullan M, Tan J
Neuronal expression of CD22: novel mechanism for inhibiting microglial proinflammatory cytokine production.
Glia. 2004 May;46(4):369-79. PubMed: 15095367PAPER Greer JM, Capecchi MR
Hoxb8 is required for normal grooming behavior in mice.
Neuron. 2002 Jan 3;33(1):23-34. PubMed: 11779477Current Filters
No filters selected